广发纳斯达克生物科技人民币(001092)
动态评分： 5.70分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2018-12-31 | NTLA | Intellia Therapeutics Inc | 16.39 | 0.08% |
| 2018-12-31 | OMER | 奥麦罗制药 | 15.02 | 0.08% |
| 2018-12-31 | RARX | Ra Pharmaceuticals Inc | 16.39 | 0.08% |
| 2018-12-31 | AMAG | AMAG Pharmaceutical Inc | 14.55 | 0.07% |
| 2018-12-31 | ANIP | ANI Pharmaceuticals Inc | 14.83 | 0.07% |
| 2018-12-31 | KURA | Kura Oncology Inc | 13.06 | 0.07% |
| 2018-12-31 | CARA | Cara Therapeutics Inc | 11.86 | 0.06% |
| 2018-12-31 | EPZM | Epizyme Inc | 11.93 | 0.06% |
| 2018-12-31 | FLXN | Flexion Therapeutics Inc | 11.89 | 0.06% |
| 2018-12-31 | GLYC | GlycoMimetics Inc | 11.23 | 0.06% |
| 2018-12-31 | PDLI | PDL BioPharma Inc | 12.18 | 0.06% |
| 2018-12-31 | PRTA | Prothena Corp plc | 11.44 | 0.06% |
| 2018-12-31 | VCYT | Veracyte Inc | 12.05 | 0.06% |
| 2018-12-31 | ADAP | Adaptimmune Therapeutics plc ADR | 10.53 | 0.05% |
| 2018-12-31 | CLXT | Calyxt Inc | 9.14 | 0.05% |
| 2018-12-31 | CRBP | Corbus Pharmaceuticals Holdings Inc | 9.3 | 0.05% |
| 2018-12-31 | CYTK | Cytokinetics Inc | 9.56 | 0.05% |
| 2018-12-31 | FPRX | Five Prime Therapeutics Inc | 9.13 | 0.05% |
| 2018-12-31 | INO | Inovio制药 | 10.15 | 0.05% |
| 2018-12-31 | NSTG | NanoString Technologies Inc | 10.66 | 0.05% |
公告&资料
